IL2RA and neoplasm: Biodistribution studies showed that Ab blocking reduced tumor uptake to 4.3 ± 0.2%ID/g (50.4% suppression compared to basal level), demonstrating specific tumor targeting of 89Zr-CD25 IgG in vivo (Figure 5).